Evidence map›Paper›PMID 33275917›Full record

SynthesisThe lancet. HIV2020

Adolescent participation in HIV research: consortium experience in low and middle-income countries and scoping review.

Suzanne Day, Bill G Kapogiannis, Seema K Shah, Erin C Wilson, Theodore D Ruel, Donaldson F Conserve, Ann Strode, Geri R Donenberg, Pamela Kohler, Catherine Slack and 3 more

Open access · greenAbstract readMeta-AnalysisScoping Review
In one paragraph

Synthesis in The lancet. HIV, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed, 2 pooled it
0.7field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 2 syntheses or guidelines pooled it, 38 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Article
  6. The HIV Reservoir and Immune Landscape Across the Life Course of Women: Implications for Cure Strategies.American journal of reproductive immunology (New York, N.Y. : 1989) · 2026
    Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Potential of Long-Acting Products to Transform the Treatment and Prevention of Human Immunodeficiency Virus (HIV) in Infants, Children, and Adolescents.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2022
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors at 10 institutions in 4 countries.

Suzanne DayInstitute for Global Health and Infectious Diseases, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA. Electronic address: suzanne.day@med.unc.edu.
Bill G KapogiannisMaternal and Pediatric Infectious Diseases Branch, Eunice Kennedy Shriver National Institute of Child Health and Human Development, Bethesda, MD, USA.
Seema K ShahDepartment of Pediatrics, Northwestern University Feinberg School of Medicine, Chicago, IL, USA; Mary Ann and J Milburn Smith Child Health Research, Outreach, and Advocacy Center, Stanley Manne Children's Research Institute, Ann and Robert H Lurie Children's Hospital of Chicago, Chicago, IL, USA.
Erin C WilsonSan Francisco Department of Public Health, San Francisco, CA, USA.
Theodore D RuelDepartment of Pediatrics, University of California, San Francisco, CA, USA.
Donaldson F ConserveDepartment of Prevention and Community Health, The George Washington University, Washington, DC, USA.
Ann StrodeSchool of Law, University of KwaZulu-Natal, University Road, Durban, South Africa.
Geri R DonenbergCenter for Dissemination and Implementation Science, Department of Medicine, University of Illinois at Chicago, Chicago, IL, USA.
Pamela KohlerDepartment of Global Health, University of Washington, Seattle, WA, USA; Department of Child, Family, and Population Health Nursing, University of Washington, Seattle, WA, USA.
Catherine SlackHIV AIDS Vaccines Ethics Group, School of Applied Human Sciences, University of KwaZulu-Natal, Scottsville, Pietermaritzburg, South Africa.
Oliver EzechiNigerian Institute of Medical Research, Medical Compound, Yaba, Lagos, Nigeria.
Joseph D TuckerInstitute for Global Health and Infectious Diseases, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA; School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA; Faculty of Infectious Diseases, London School of Hygiene & Tropical Medicine.
PATC3H Consortium Adolescent Bioethics Working Group
University of KwaZulu-Natal · ZAUniversity of North Carolina at Chapel Hill · USEunice Kennedy Shriver National Institute of Child Health and Human Development · USGeorge Washington University · USLurie Children's Hospital · USNigerian Institute of Medical Research · NGSan Francisco Department of Public Health · USUniversity of California, San Francisco · USUniversity of Illinois Chicago · USUniversity of Washington · US

Funding

The FIOCRUZ Therapeutic and Prevention HIV/AIDS Clinical Trials Unit (FioTrials)UM1AI069476 · NIAID · FUNDACAO OSWALDO CRUZ · PI BEATRIZ GRINSZTEJN · 2012 to 2026
$26.3M
ITEST: Innovative Tools to Expand Youth-Friendly HIV Self-TestingUH3HD096929 · NICHD · WASHINGTON UNIVERSITY · PI EZECHI, OLIVER CHUKWUJEKWU, IWELUNMOR, JULIET · 2020 to 2022
$4.4M
Strategic antiretroviral therapy and HIV testing for youth in rural Africa (SATURN)UG3HD096915 · NICHD · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI HAVLIR, DIANE V · 2018 to 2019
$3.4M
ITEST: Innovative Tools to Expand Youth-Friendly HIV Self-TestingUG3HD096929 · NICHD · SAINT LOUIS UNIVERSITY · PI EZECHI, OLIVER CHUKWUJEKWU, IWELUNMOR, JULIET · 2018 to 2019
$2.3M
CombinADO: a combination intervention strategy to improve health outcomes for adolescents living with HIVUG3HD096926 · NICHD · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI ABRAMS, ELAINE JANINE · 2018 to 2019
$2.2M
Developing and Testing a Multi-level Package of Interventions for an Integrated Care Delivery Model of HIV Prevention and Treatment Targeting Adolescent Girls in ZambiaUG3HD096908 · NICHD · RESEARCH TRIANGLE INSTITUTE · PI SUBRAMANIAN, SUJHA · 2018 to 2019
$2.1M
Intensive Combination Approach to Rollback the Epidemic (iCARE) in Nigerian AdolescentsUG3HD096920 · NICHD · NORTHWESTERN UNIVERSITY AT CHICAGO · PI GAROFALO, ROBERT, TAIWO, BABAFEMI O · 2018 to 2020
$2.0M
Data-informed Stepped Care (DiSC) to Improve Adolescent HIV OutcomesUG3HD096906 · NICHD · UNIVERSITY OF WASHINGTON · PI JOHN-STEWART, GRACE C., KOHLER, PAMELA · 2018 to 2019
$1.9M
Mentoring Multidisciplinary Global HIV Patient-Oriented ResearchK24AI143471 · NIAID · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Joseph David Tucker · 2019 to 2026
$1.4M
Multilevel Comprehensive HIV Prevention for South African Adolescent Girls and Young WomenUG3HD096875 · NICHD · UNIVERSITY OF ILLINOIS AT CHICAGO · PI BEKKER, LINDA-GAIL GAIL, DONENBERG, GERI R · 2018 to 2019
$1.2M
Acceptability and Feasibility of Unsupervised HIV Self-Testing Among Networks of Men in TanzaniaR00MH110343 · NIMH · UNIVERSITY OF SOUTH CAROLINA AT COLUMBIA · PI CONSERVE, DONALDSON · 2018 to 2020
$765k
Enhancing Partner Services among Men Who Have Sex with Men Living With HIV: A Pilot Randomized Controlled TrialR34MH119963 · NIMH · UNIV OF NORTH CAROLINA CHAPEL HILL · PI TANG, WEIMING, TUCKER, JOSEPH DAVID · 2019 to 2021
$568k
NIAID NIH HHS K24 AI143471NIAID NIH HHS UM1 AI069476NICHD NIH HHS UG3 HD096875NICHD NIH HHS UG3 HD096906NICHD NIH HHS UG3 HD096908NICHD NIH HHS UG3 HD096914NICHD NIH HHS UG3 HD096915NICHD NIH HHS UG3 HD096920NICHD NIH HHS UG3 HD096926NICHD NIH HHS UG3 HD096929NICHD NIH HHS UH3 HD096929NIMH NIH HHS K99 R00MH110343NIMH NIH HHS R00 MH110343NIMH NIH HHS R34 MH119963
6 · The paper itself

Abstract

Adolescents in low and middle-income countries (LMICs) have a high prevalence of HIV, therefore, it is important that they are included in HIV research. However, ethical challenges regarding consent can hinder adolescent research participation. We examined examples from the Prevention and Treatment Through a Comprehensive Care Continuum for HIV-affected Adolescents in Resource Constrained Settings (PATC3H) research consortium, which investigates adolescent HIV prevention and treatment in seven LMICs: Brazil, Kenya, Mozambique, Nigeria, South Africa, Uganda, and Zambia. PATC3H researchers were asked to identify ethical and practical challenges of adolescent consent to research participation in these countries. We also did a scoping review of strategies that could improve adolescent participation in LMIC HIV studies. Examples from PATC3H research highlighted many ethical challenges that affect adolescent participation, including inconsistent or absent consent guidance, guidelines that fail to account for the full array of adolescents' lives, and variation in how ethical review committees assess adolescent studies. Our scoping review identified three consent-related strategies to expand adolescent inclusion: waiving parental consent requirements, allowing adolescents to independently consent, and implementing surrogate decision making. Our analyses suggest that these strategies should be further explored and incorporated into ethical and legal research guidance to increase adolescent inclusion in LMIC HIV research.

Indexed as

Age FactorsDeveloping CountriesEthics, ResearchHIV InfectionsHumansResearchSocioeconomic Factors

Identifiers

PMID33275917
PMCPMC8491773
OpenAlexW3109319969

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.